Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.65    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.05 (1.075%)
Market Cap: £223.18m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Major Industry Awards Win

10 Apr 2006 09:19

Seeing Machines Limited10 April 2006 Seeing Machines Limited ("Seeing Machines" or the "Company") Monday 10 April 2006 Seeing Machines Wins Major Industry Awards for Glaucoma Project Seeing Machines (AIM:SEE) was awarded two iAwards at the AIIA's galapresentation dinner last Friday night (7 April) for its glaucoma diagnosticdevice development. • The "Local Industry Award" - for the most innovative ICT project undertaken by an Australian local industry company (small-to-medium enterprise), and • The "Research and Development Award" - for the most outstanding ICT R& D project The iAwards, Australia's premier industry awards for the Information andCommunications Technology (ICT) sector, are awarded by the AustralianInformation Industry Association (AIIA) for outstanding ICT solutions across 15categories from Agriculture & Primary Industries, e-Government & Service,Research & Development through to Tourism & Hospitality. In addition there arefive major awards: the Local Industry Award, Community Award, InnovativeCommercial Software Award, the Inspiration Award and the CSIRO Tony BensonAward. Seeing Machines won the iAward for the Research and Development category, andthen also picked up the major Local Industry Award for the most innovative ICTproject undertaken by an Australian SME. Seeing Machines is developing the world's first non-contact objective device fordiagnosing glaucoma and a range of other eye diseases, utilising itsmarket-leading, patent-protected computer vision technology. These nationalawards recognize the progress that has been made to date in this project and thesignificant commercial opportunity arising from the pioneering work of theSeeing Machines team and its colleagues at the Research School of BiologicalSciences at the Australian National University. Seeing Machines would like tothank the AIIA for its recognition of this important work. The full list of iAwards is available at: www.aiia.com.au/i-cms.isp?page=1290. -- ends -- Enquiries: Seeing Machines Limited Insinger de Beaufort Parkgreen CommunicationsNick Cerneaz, CEO Simon Fox Justine Howarth / Victoria Thomas+61 (0) 2 6125 6501 +44 (0) 20 7190 7018 +44 (0) 20 7493 3713www.seeingmachines.com About the AIIA and the iAwards Details about the Australian Information Industry Association (AIIA) areavailable here: www.aiia.com.au/i-cms.isp?page=13 Details about the iAwards are available here: www.aiia.com.au/i-cms.isp?page=243. About Seeing Machines Seeing Machines is an award winning Technology Company which focuses on visionbased human machine interfaces. Formed in 2000 in Canberra, Australia, SeeingMachines' purpose is to commercialise its computer-vision across a range ofindustries and applications. Seeing Machines deliver advanced computer vision solutions for researches anddeveloper in human factors, transportation safety, computer human interaction,robotics, medical research and psychology. The flagship product faceLABTMprovides an automated and contact-free gaze and head tracking technology, itsolves the problem of observing human behaviour naturally, non-intrusively andwith a high degree of accuracy and usability. faceLABTM is a computer vision system that is able to measure the orientationand position of a human head, as well as detect blinks and estimategaze-direction. It achieves all of this completely visually through a stereocamera system connected to advanced image processing software, with noattachments required on the subject. The product is designed to allow humanfactors researchers and designers assess the interaction of an operator in anenvironment and this finds application in designing operator environments, suchas cockpits for cars, trucks, trains, and aeroplanes for instance, and otherindustrial design applications, as well as medical and psychological researchsituations. The technology also has application in monitoring automobiledrivers and if it detects drowsiness or that the driver is distracted and theirattention has been diverted from the road, an alarm can be raised to alert thedriver to either pull over and rest in the case of drowsiness or to pay moreattention to the road. faceLABTM works in real-time, enabling the behaviour of a subject to be tracked.This technology is paving the way in promoting safer driving conditions andworks to enhance the driving experience and to eliminate accidents causedthrough driver drowsiness or distraction. There are many different sectors that can benefit from this revolutionarysoftware, for which it has been developed, including: automotive; academicresearch; medicine/healthcare; defence; autostereoscopy (next generationdisplays); sport; and games. Seeing Machines is currently working with researchers from the Research Schoolof Biological Sciences at the Australian National University to enable a newobjective method for diagnosing and managing glaucoma, a leading source ofblindness. This technology could complement or replace existing visual fieldtesting devices used by more than 70,000 ophthalmologists globally and may haveapplication in detecting other eye and neurological diseases. Seeing Machinesis developing a technology based on a completely objective method that uses aninvoluntary physiological response. This has the potential to become a 'goldstandard' in the diagnosis and management of glaucoma to derive reliable,repeatable results and greater diagnostic accuracy. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th May 20267:00 amRNSUS$3.8m Order for Guardian BdMS
6th May 20267:00 amRNSQ3 FY2026 Quarterly KPIs
20th Apr 202612:30 pmRNSHolding(s) in Company
10th Apr 20268:53 amRNSStatement re alleged cyber threat
27th Mar 20267:00 amRNSHalf-year Financial Report
24th Feb 20267:00 amRNS-RPublication of Investor Presentation
18th Feb 20267:00 amRNSTrading Update - H1 FY2026
13th Feb 20267:30 amRNSAppointment of Joint Broker
11th Feb 20267:00 amRNSQ2 FY2026 Quarterly KPIs
13th Jan 202612:00 pmRNS-R3D Cabin Perception Mapping breaks new ground
6th Jan 20267:00 amRNSAgreement
5th Jan 20267:00 amRNS-R3D Cabin Perception Mapping to be unveiled at CES
5th Jan 20267:00 amRNSHolding(s) in Company
2nd Jan 20267:00 amRNS-RSeeing Machines Announces Future Mobility Group
2nd Jan 20267:00 amRNS-RSeeing Machines Announces Future Mobility Group
17th Dec 20257:00 amRNS-RTechnical Paper Series - Intoxication launched
4th Dec 20257:00 amRNS-RSeeing Machines 2025 Guardian Insights Report
27th Nov 20257:00 amRNSResults of AGM
26th Nov 20257:30 amRNSJapanese Auto Award and Extended European Program
12th Nov 20257:05 amRNSQ1 FY2026 Quarterly KPIs
12th Nov 20257:00 amRNSGuardian order from US-based multinational company
6th Nov 20257:05 amRNS-RCollaboration with Magna milestone in China
3rd Nov 20257:00 amRNSBoard Changes
3rd Nov 20257:00 amRNSNotice of Annual General Meeting
30th Oct 20257:00 amRNSLATAM Distributor Orders 1,300 Guardian Units
29th Oct 20257:00 amRNSAdvanced Development Project with Japanese OEM
8th Oct 20257:00 amRNSUS$1.8m expansion order for Guardian BdMS
26th Sep 20257:00 amRNSExpanding Guardian prospects across Europe
25th Sep 20257:00 amRNSFY2025 Results and Annual Financial Report
24th Sep 20257:20 amRNSFirst Guardian contract through Mitsubishi
10th Sep 20257:05 amRNS-RSeeing Machines Launches Impairment Capability
10th Sep 20257:00 amRNSNotice of Results and Presentation
29th Aug 202510:10 amRNSDirector Dealing
21st Aug 20257:00 amRNSFY2025 Trading Update
5th Aug 20257:00 amRNSQ4 FY2025 Quarterly KPIs
30th Jun 20257:00 amRNSMitsubishi Electric Europe Guardian collaboration
27th Jun 20257:00 amRNSUS Guardian Gen 3 trial with Mitsubishi Electric
16th Jun 20258:59 amRNS$1.2 Million Agreement with Global Auto Leader
9th May 20252:31 pmRNSDirector dealing
1st May 20257:00 amRNSQ3 FY2025 Quarterly KPIs
29th Apr 20259:58 amRNSNotification of Major Holdings
8th Apr 20258:53 amRNSHoldings in Company
8th Apr 20257:00 amRNSDirector/PDMR Shareholding
4th Apr 20257:00 amRNSDirector dealing
2nd Apr 202511:00 amRNSLondon presentation for investors and analysts
2nd Apr 20257:00 amRNSDirector dealing
2nd Apr 20257:00 amRNSDirector dealing
1st Apr 202512:00 pmRNS-RSeeing Machines Announces 3D Camera Technology
31st Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Mar 20257:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.